Discover 443 paid clinical trials in Tucson, Arizona. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
With major studies in this city focused on conditions like Alzheimer's disease, lymphoma, asthma, and various forms of cancer, Tucson offers participants access to innovative care and breakthrough treatments. The city’s strong research network provides opportunities for individuals seeking to explore new treatment options while making a positive impact on medical research and advancements in healthcare.
Filter
2
Filter results
Results: 443
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
for
Ganglioneuroblastoma, Nodular, Neuroblastoma
Location: Tucson AZ, Mesa AZ, Phoenix AZ, El Paso TX,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 0 - 30
Code: NCT06172296
Phase 3, Recruiting
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
for
Smoldering Plasma Cell Myeloma
Location: Tucson AZ, Phoenix AZ, Goodyear AZ, Kingman AZ,
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: All
Age: 18+
Code: NCT03937635
Phase 3, Recruiting
Project: Every Child for Younger Patients With Cancer
for
Adrenal Gland Pheochromocytoma, Carcinoma In Situ,
Location: Tucson AZ, Mesa AZ, Phoenix AZ, El Paso TX, Kingman AZ,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 25
Code: NCT02402244
Recruiting
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
for
Metastatic Malignant Neoplasm in the Lung,
Location: Tucson AZ, Mesa AZ, Phoenix AZ, El Paso TX, Kingman AZ,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 50
Code: NCT05235165
Phase 3, Recruiting
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
for
Acute Myeloid Leukemia
Location: Tucson AZ, Mesa AZ, Phoenix AZ, El Paso TX,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 21
Code: NCT04293562
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer
for
Hematopoietic and Lymphatic System Neoplasm,
Location: Tucson AZ, Phoenix AZ, El Paso TX, Albuquerque NM,
Sponsor: Children's Oncology Group
Sex: Female
Age: 0 - 39
Code: NCT06513962
Phase 3, Recruiting
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors
for
Metastatic Malignant Neoplasm in the Liver,
Location: Tucson AZ, Gilbert AZ, Phoenix AZ, Kingman AZ,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT05040360
Phase 2, Recruiting
Strategy for Improving Stroke Treatment Response
for
Ischemic Stroke
Location: Tucson AZ, Phoenix AZ, San Diego CA, La Jolla CA,
Sponsor: Translational Sciences, Inc.
Sex: All
Age: 18+
Code: NCT05948566
Phase 2, Recruiting
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
Location: Tucson AZ, Las Vegas NV, Irvine CA, Orange CA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07218380
Phase 3, Recruiting
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
for
Breast Neoplasms, Neoplasm Metastasis
Location: Tucson AZ, Chandler AZ, El Paso TX, Oceanside CA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07174336
Phase 3, Recruiting
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
for
Metastatic Castration-Resistant Prostate Cancer
Location: Tucson AZ, Scottsdale AZ, Goodyear AZ, Albuquerque NM,
Sponsor: Kyntra Bio
Sex: Male
Age: 18+
Code: NCT06842498
Phase 2, Recruiting
Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )
for
Pancreatic Cancer, Pancreatic Cancer Metastatic, PDAC,
Location: Tucson AZ, Phoenix AZ, Houston TX, Rochester MN,
Sponsor: Revolution Medicines, Inc.
Sex: All
Age: 18+
Code: NCT07621718
Phase 3, Recruiting
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
for
Carcinoma, Non-Small-Cell Lung
Location: Tucson AZ, San Diego CA, Oceanside CA, Orange CA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT06890598
Phase 3, Recruiting
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Location: Tucson AZ, Gilbert AZ, Phoenix AZ, Fort Bliss TX,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT06119581
Phase 3, Recruiting
Study to Learn About the Safety of Fazirsiran and if it Can Help People With Alpha-1 Antitrypsin Liver Disease With Mild Liver Scarring (Fibrosis)
for
Alpha1-Antitrypsin Deficiency
Location: Tucson AZ, Phoenix AZ, La Jolla CA, Los Angeles CA,
Sponsor: Takeda
Sex: All
Age: 18 - 70+
Code: NCT06165341
Phase 3, Recruiting
A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
for
Primary Generalized Tonic-Clonic Seizures
Location: Tucson AZ, Phoenix AZ, El Paso TX, Orange CA,
Sponsor: Xenon Pharmaceuticals Inc.
Sex: All
Age: 12+
Code: NCT05667142
Phase 3, Recruiting
Facilitating Adjustment to Simulated Jet Lag
for
Circadian Rhythm Sleep Disorder, Jet Lag Type
Location: Tucson AZ
Sponsor: University of Arizona
Sex: All
Age: 18 - 45
Code: NCT05382923
Recruiting
Arizona CEAL: Linking Social Care With Healthcare Systems to Address SDOH
for
Social Determinants of Health (SDOH), Hypertension,
Location: Tucson AZ
Sponsor: Sairam Parthasarathy
Sex: All
Age: 18+
Code: NCT07799961
Recruiting
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations